Actavis has completed its acquisition of Allergan for a total value of around $70.5bn. The combination of the two companies will create one of the world's top ten pharma companies by sales revenue, with combined annual pro forma revenue of more than $23bn anticipated for this year. Brent Saunders, CEO and president of Actavis, said:
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!